Sinopharm Group Correlations

X2S Stock

EUR 2.04 0.01 0.49%

The current 90-days correlation between Sinopharm Group and TEXAS ROADHOUSE is 0.04 (i.e., Significant diversification). The correlation of Sinopharm Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Sinopharm Group Correlation With Market

Significant diversification

The correlation between Sinopharm Group Co and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sinopharm Group Co and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Sinopharm Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sinopharm Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sinopharm Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sinopharm Group Co to buy it.

Moving together with Sinopharm Stock

0.64	S1R	Shanghai Pharmaceuticals	Pair Corr
0.89	X2S1	SINOPHARM GROUP 15ON	Pair Corr
0.69	CYL	CryoLife	Pair Corr
0.68	CYL	CRYOLIFE	Pair Corr

Moving against Sinopharm Stock

0.53	DBPD	Xtrackers ShortDAX	Pair Corr
0.5	EII	Eisai	Pair Corr
0.31	59Z	MEDIPAL HOLDINGS P	Pair Corr

Related Correlations Analysis

	TBCN	ROW	DG9	9IRA	CN6	ROW	P5IB	CS2
TBCN		-0.03	0.0	0.66	0.53	-0.01	0.27	0.67	TBCN
ROW	-0.03		0.0	0.22	0.18	0.95	-0.64	-0.09	ROW
DG9	0.0	0.0		0.0	0.0	0.0	0.0	0.0	DG9
9IRA	0.66	0.22	0.0		0.71	0.25	-0.05	0.53	9IRA
CN6	0.53	0.18	0.0	0.71		0.22	0.02	0.6	CN6
ROW	-0.01	0.95	0.0	0.25	0.22		-0.64	-0.06	ROW
P5IB	0.27	-0.64	0.0	-0.05	0.02	-0.64		0.06	P5IB
CS2	0.67	-0.09	0.0	0.53	0.6	-0.06	0.06		CS2
	TBCN	ROW	DG9	9IRA	CN6	ROW	P5IB	CS2

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ROW	+ 0.95	ROW
CN6	+ 0.71	9IRA
CS2	+ 0.67	TBCN
9IRA	+ 0.66	TBCN
CS2	+ 0.6	CN6
CN6	+ 0.53	TBCN

High negative correlations

P5IB	- 0.64	ROW
P5IB	- 0.64	ROW
CS2	- 0.09	ROW
CS2	- 0.06	ROW
P5IB	- 0.05	9IRA
ROW	- 0.03	TBCN

Risk-Adjusted Indicators

There is a big difference between Sinopharm Stock performing well and Sinopharm Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sinopharm Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
TBCN	1.87	0.57	0.11	(2.57)	1.28	(3.98)	5.71	(2.78)	16.16
ROW	1.44	0.34	0.00	(0.33)	1.40	(1.53)	4.60	(2.23)	8.77
DG9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
9IRA	3.29	0.80	0.12	(0.80)	3.14	(4.67)	8.06	(5.59)	29.59
CN6	1.44	0.30	0.03	(6.13)	1.28	(2.45)	3.80	(2.03)	9.33
ROW	1.39	0.03	(0.03)	0.26	1.45	(1.56)	4.17	(2.51)	7.92
P5IB	2.51	0.05	(0.01)	0.46	3.40	(9.31)	9.09	(8.33)	19.09
CS2	1.44	0.34	0.02	(0.46)	1.36	(2.00)	4.11	(2.24)	14.81

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sinopharm Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Manager Now

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital

All Next

Launch Module

Sinopharm Group Corporate Management

Elected by the shareholders, the Sinopharm Group's board of directors comprises two types of representatives: Sinopharm Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sinopharm. The board's role is to monitor Sinopharm Group's management team and ensure that shareholders' interests are well served. Sinopharm Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sinopharm Group's outside directors are responsible for providing unbiased perspectives on the board's policies.

Yijian Wu	Company Board	Profile
Xiaojuan Li	Chief Officer	Profile
Qingming Yu	Ex Chairman	Profile
Yong Liu	Pres Director	Profile
Shuangjun Xu	NonEx VP	Profile
Xiuchang Jiang	CFO VP	Profile
Wanyong Lian	VP	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC